Audion Therapeutics Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Audion Therapeutics General Information
Description
Operator of a clinical-stage company intended to develop therapies to treat hearing loss. The company is involved in the discovery of disease-intervention therapies through an approach of restoring the function of hearing by targeting a protein complex called gamma-secretase, enabling medical professionals to address sensorineural loss due to aging more efficiently.
Contact Information
Website
www.audiontherapeutics.comCorporate Office
- Hogeweg 54
- 1098 CE Amsterdam
- Netherlands
Corporate Office
- Hogeweg 54
- 1098 CE Amsterdam
- Netherlands
Audion Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | 03-Oct-2024 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 24-Sep-2015 | Completed | Generating Revenue | |||
| 2. Grant | 08-Sep-2015 | $6.46M | Completed | Generating Revenue | ||
| 1. Later Stage VC (Series A) | 10-Feb-2014 | Completed | Generating Revenue |
Audion Therapeutics Comparisons
Industry
Financing
Details
Audion Therapeutics Competitors (19)
One of Audion Therapeutics’s 19 competitors is Akouos, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Akouos | Formerly VC-backed | Boston, MA | ||||
| Acousia Therapeutics | Venture Capital-Backed | Tubingen, Germany | ||||
| Rinri Therapeutics | Venture Capital-Backed | Sheffield, United Kingdom | ||||
| Neurona Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Sensorion | Formerly VC-backed | Montpellier, France |
Audion Therapeutics Patents
Audion Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2735139-T3 | Inhibitory compounds of notch path signaling | Active | 07-Jul-2015 | ||
| AU-2016289822-A1 | Notch pathway signaling inhibitor compounds | Active | 07-Jul-2015 | ||
| AU-2016289822-B2 | Notch pathway signaling inhibitor compounds | Active | 07-Jul-2015 | ||
| CA-2987431-A1 | Notch pathway signaling inhibitor compounds | Active | 07-Jul-2015 | ||
| EP-3319967-A1 | Notch pathway signaling inhibitor compounds | Active | 07-Jul-2015 | C07D487/04 |
Audion Therapeutics Signals
Audion Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LabCentral | Accelerator/Incubator |
Audion Therapeutics FAQs
-
When was Audion Therapeutics founded?
Audion Therapeutics was founded in 2008.
-
Where is Audion Therapeutics headquartered?
Audion Therapeutics is headquartered in Amsterdam, Netherlands.
-
What is the size of Audion Therapeutics?
Audion Therapeutics has 2 total employees.
-
What industry is Audion Therapeutics in?
Audion Therapeutics’s primary industry is Drug Discovery.
-
Is Audion Therapeutics a private or public company?
Audion Therapeutics is a Private company.
-
What is Audion Therapeutics’s current revenue?
The current revenue for Audion Therapeutics is .
-
How much funding has Audion Therapeutics raised over time?
Audion Therapeutics has raised $2.81M.
-
Who are Audion Therapeutics’s investors?
LabCentral has invested in Audion Therapeutics.
-
Who are Audion Therapeutics’s competitors?
Akouos, Acousia Therapeutics, Rinri Therapeutics, Neurona Therapeutics, and Sensorion are some of the 19 competitors of Audion Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process